Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.

Three New Reports on Society Pass (SOPA) With Price Targets from $3.00 to $4.00. (All Report Archive)

GeoVax (GOVX) Research Reports Archive

Research Report Archive Reports from Robert LeBoyer at Noble Capital. Jeffrey Kraws and Karen Goldfarb at Crystal Research....

Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.

Wall Street Cozy's up to Ardelyx After New Guidance. On January 8th, Mike Raab, President and Chief Executive...

Is David Dodd on to his Next Billion Dollar Payday for Shareholders?

Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors. GeoVax (GOVX) Completes Patient...

Pharmather (PHRRF) Has Officially Broken Out.

Read Corporate Presentation Today. Pharmather (PHRRF) which we gave a 'heads-up,' because looked like it was about to break...

Post Reverse Split Mania!

Now Wait a Minute, Aren't Stocks That do Reverse Splits Supposed go Down and Stay Down? First our...

Adding Geovax (GOVX) to 2024 Biotech Watch List.

GEOVAX (GOVX) $0.32 We added this to the Watch List earlier in the...

LQR House (LQR) Commits to Postpone Public Offerings for the Foreseeable Future.

LQR House Initiates Warrants Cancellation and Commits to Postpone Public Offerings for the Foreseeable Future

PharmaTher (PHRRF) Breaks Above Resistance.

We're now up 325% in just Under a Year. Last "big" News was Receiving a Priority Original Abbreviated New Drug Application,...

Ardelyx (ARDX) Firmly Above Resistance.

Were not traders and we don't do technical analysis, but we could see this coming from a mile away. Next stop $9.00...

Latest article

Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...